Market Access
Europe’s new HTA reality: The JCA, one year on
Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.
R&D
Clinical Trials Round-Up: May and June 2026
May and June delivered a plethora of clinical trial updates. In the build-up to ASCO in June, our inbox was overflowing with oncology trial results.
Sales & Marketing
M&A trends in diagnostics and life sciences tools
The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large corporates.
Market Access
Why global pharmaceutical reforms are quietly redirecting ra...
Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
R&D
Integrate or isolate: Incorporating traditional safety-relat...
Should traditional safety considerations be treated as distinct from broader ESG frameworks, or fully integrated within them?
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
